4//SEC Filing
TANANBAUM JAMES B 4
Accession 0001209191-08-043439
CIK 0001232524other
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 4:10 PM ET
Size
12.5 KB
Accession
0001209191-08-043439
Insider Transaction Report
Form 4
TANANBAUM JAMES B
Director
Transactions
- Purchase
Common Stock
2008-07-21+187,479→ 1,403,129 total(indirect: By Prospect Venture Partners II, L.P.) - Purchase
Common Stock Warrant (right to buy)
2008-07-21+84,365→ 84,365 total(indirect: By Prospect Venture Partners II, L.P.)Exercise: $7.37From: 2009-01-21Exp: 2014-07-21→ Common Stock (84,365 underlying) - Purchase
Common Stock Warrant (right to buy)
2008-07-21+1,285→ 1,285 total(indirect: By Prospect Associates II, L.P.)Exercise: $7.37From: 2009-01-21Exp: 2014-07-21→ Common Stock (1,285 underlying) - Purchase
Common Stock
2008-07-21+2,855→ 21,366 total(indirect: By Prospect Associates II, L.P.)
Footnotes (4)
- [F1]The reported securities are included within 187,479 units purchased by Prospect Venture Partners II, L.P. ("PVP II") for $6.75625 per unit. Each unit consists of one share of Common Stock and one warrant to purchase 0.45 of a share of Common Stock.
- [F2]The shares are owned by PVP II, which is under common control with Prospect Associates II, L.P. ("PA II"). Prospect Management Co. II, L.L.C. ("PMC II") serves as the sole general partner of PVP II. James B. Tananbaum, M.D. is a Managing Director of PMC II and shares voting and investment power over the shares held by PVP II. The Reporting Person disclaims beneficial ownership of the shares held by PVP II except to the extent of his proportionate pecuniary interest therein.
- [F3]The reported securities are included within 2,855 units purchased by PA II for $6.75625 per unit. Each unit consists of one share of Common Stock and one warrant to purchase 0.45 of a share of Common Stock.
- [F4]The shares are owned by PA II. PMC II serves as the sole general partner of PA II. James B. Tananbaum, M.D. is a Managing Director of PMC II and shares voting and investment power over the shares held by PA II. The Reporting Person disclaims beneficial ownership of the shares held by PA II except to the extent of his proportionate pecuniary interest therein.
Documents
Issuer
JAZZ PHARMACEUTICALS INC
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001162061
Filing Metadata
- Form type
- 4
- Filed
- Jul 22, 8:00 PM ET
- Accepted
- Jul 23, 4:10 PM ET
- Size
- 12.5 KB